Tag
Neuralink has advanced from a 2021 macaque Pong demo to a human trial, with paralyzed participant Audrey Crews, who received an implant in July 2025, now drawing and signing her name using thought-controlled cursor movement.
Researchers at the University of Cambridge have developed the first entirely AI-designed vaccine, which targets entire virus families and has successfully completed a Phase I human trial showing safety and broad immune response.